<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A prospective study of Nigerian children with <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> was undertaken to determine serum levels of antithrombin III (AT-III) and compare these with <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain>Mean serum AT-III was significantly lower in patients than in controls (14.51 +/- 4.84 mg/dl and 17.75 +/- 5.92 mg/dl) respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Seven of the 49 sickle cell patients had AT-III levels below 50% of <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="3" pm="."><plain>Mean platelet counts were significantly higher in sicklers than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="4" pm="."><plain>AT-III deficiency may predispose to thrombotic complications in children with <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> </plain></SENT>
</text></document>